Thromb Haemost 1976; 36(01): 286-288
DOI: 10.1055/s-0038-1648038
Letter to the Editor
Schattauer GmbH

ADP, Ristocetin, Bovine Factor VIII and Thrombasthenic Platelets

G Miragliotta*
1   Laboratory for Haemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea, 62 – 20157 Milano, Italy
2   Department of Internal Medicine, Ospedale Maggiore, Bergamo, Italy
,
G Remuzzi
1   Laboratory for Haemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea, 62 – 20157 Milano, Italy
2   Department of Internal Medicine, Ospedale Maggiore, Bergamo, Italy
,
B Minetti
1   Laboratory for Haemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea, 62 – 20157 Milano, Italy
2   Department of Internal Medicine, Ospedale Maggiore, Bergamo, Italy
,
G de Gaetano
1   Laboratory for Haemostasis and Thrombosis Research, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea, 62 – 20157 Milano, Italy
2   Department of Internal Medicine, Ospedale Maggiore, Bergamo, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

 

* On leave of absence from the Institute of Microbiology, University of Bari Medical School, Bari, Italy.


 
  • References

  • 1 Bottecchia D, Vermylen J. 1976 Factor VIII and platelet aggregation. I. Aggregation of human platelets by subunits of bovine factor VIII. British Journal of Haematology. in press.
  • 2 Caen J. P, Cronberg S, Levy-Toledano S, Kubisz P, Pinkhas J. P. 1971; New data on Glanzmann’s thrombasthenia. Proceedings of the Society for Experimental Biology and Medicine 136: 1082.
  • 3 Cohen I, Glaser T, Seligsohn U. 1975; Effects of ADP and ATP on bovine fibrinogen- and ristocetin-induced platelet aggregation in Glanzmann’s thrombasthenia. British Journal of Haematology 31: 343.
  • 4 de Gaetano G, Bottecchia D, Vermylen J. 1973; Retraction of reptilase-clots in the presence of agents inducing or inhibiting the platelet adhesion-aggregation reaction. Thrombosis Research 2: 71.
  • 5 de Gaetano G, Miragliotta G, Roncucci R, Lansen J, Lambelin G. 1976; Suloctidil: a novel inhibitor of platelet aggregation in human beings. Thrombosis Research 8: 361.
  • 6 Donati M. B, de Gaetano G, Vermylen J. 1973; Evidence that bovine factor VIII, not bovine fibrinogen, aggregates human platelets. Thrombosis Research 2: 97.
  • 7 Jenkins C. S. P, Meyer D, Dreyfus M. D, Larrieu M. J. 1974; Willebrand factor and ristocetin. I. Mechanism of ristocetin-induced platelet aggregation. British Journal of Haematology 28: 561.
  • 8 Kattlove H. E, Gomez M. H. 1975; Studies on the mechanism of ristocetin-induced platelet aggregation. Blood 45: 91.
  • 9 Kirby E. P, Mills D. C. B. 1975; The interaction of bovine factor VIII with human platelets. Journal of Clinical Investigation 56: 491.
  • 10 Praga C, Cortellaro M, Pogliani E. 1972. Standardized bleeding time in the study of drugs in-terferig with platelet function. In: Mannucci P. M, Gorini S. (eds.), Platelet Function and Thrombosis — A Review of Methods. Plenum Press; New York: 149.
  • 11 Reichert N, Seligsohn U, Ramot B. 1975; Clinical and genetic aspects of Glanzmann’s thrombasthenia in Israel, (Report of 22 cases). Thrombosis et Diathesis Haemorrhagica 34: 806.
  • 12 Vermylen J, Bottecchia D, Szpilman H. 1976 Factor VIII and platelet aggregation. III. Further studies on aggregation of human platelets by neuraminidase-treated human factor VIII. British Journal of Haematology. in press.
  • 13 Vermylen J, de Gaetano G, Donati M. B, Verstraete M. 1974; Platelet-aggregating activity in neuraminidase-treated human cryoprecipitates: its correlation with factor-VIII-related antigen. British Journal of Haematology 26: 645.
  • 14 Vermylen J, Donati M. B, de Gaetano G, Verstraete M. 1973; Aggregation of human platelets by bovine or human factor VIII. Role of carbohydrate side-chains. Nature 244: 167.
  • 15 Weiss H. J. 1975; Abnormalities of factor VIII and platelet aggregation-use of ristocetin in diagnosing the von Willebrand syndrome. Blood 45: 403.